Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
about
3,4-methylenedioxymethamphetamine (MDMA): current perspectivesGang youth, substance use, and drug normalization.MDMA alters emotional processing and facilitates positive social interaction.Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (Ecstasy) in rats: role of drug context.Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.Paradoxical effects of low dose MDMA on latent inhibition in the ratMaximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users.Poly-Drug Use among Ecstasy Users: Separate, Synergistic, and Indiscriminate PatternsHallucinogen use disorders among adult users of MDMA and other hallucinogens.Factorial structure of the Brief Symptom Inventory (BSI)-18 among Chinese drug users.Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder.Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?Nonmedical prescription stimulant use among a sample of college students: relationship with psychological variables.Are ecstasy users biased toward endorsing somatic mental health symptoms? Results from a general community sample.A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users.Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective.Modelling the adverse effects associated with ecstasy use.Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.Heterogeneity in drug abuse among juvenile offenders: is mixture regression more informative than standard regression?Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.Variations in mental health problems, substance use, and delinquency between African American and Caucasian juvenile offenders: implications for reentry services.Is there a case for MDMA-assisted psychotherapy in the UK?
P2860
Q24602762-1BFB6404-182B-4BDB-8ADF-AA247417ABECQ34163127-9AF29ADE-74A6-4271-AA15-472CF9E31766Q34325163-FC02AE55-2285-47D3-9469-C103035259DFQ34329874-50C53496-1F36-4D95-871A-D69BE63DB8DCQ36123239-AAD8B418-1E2C-422C-8CF7-283316D19491Q36615013-DB2FABC8-D2B3-44A8-8C03-812F4C5BD381Q37021831-8C9DAC04-1EF4-408C-B943-AF40D955F087Q37031438-B3F0F392-37AD-470B-8776-6621BAFA53E0Q37059831-F82B69E5-8945-4A2D-9A9C-6C52A0BF1E7BQ37110890-3946FB51-89B6-4421-9FB3-1D1F325B4E3BQ37282367-E78C8C5E-3AB7-44EC-8015-6AFB1D48704DQ37323629-05A14FEB-BD9D-4F8E-884C-017DAFDA97C2Q37351168-7FF4A195-A3A3-47BF-924D-13A22753B513Q40157269-50905465-3426-4CE4-974E-F647AC53CA0AQ40300253-DBC28397-A2FF-4E74-84F0-383DBF532256Q43273914-E8C30B6E-133D-4D93-831E-AC5F2B207410Q44880265-94F6DF76-717B-4C7A-A7BA-1E8ABE73643AQ45099576-287D0F5B-1782-4083-81FD-B2E5829E7B36Q46477520-1F8C5F82-617F-4C8D-BAA5-20BA18B7F613Q46970747-412A6DD6-3260-44C4-8C6E-9FEF3DD77417Q48325721-976B1EFD-510C-4DCA-ACF5-8425CB747918Q50588931-63A29179-7AEF-431E-B800-EF1EC77D9A97Q50740871-28E1C401-A3D7-47BB-84A9-5A6DD72C092BQ51482811-B0F6D973-6F85-46B8-9DAF-83B5AB25C09CQ51900178-B372219E-F769-4003-917C-7A0E1F1FB988Q53203541-6B67A7B3-7401-4D27-B677-61A1C33EE3F0
P2860
Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Problematic versus non-problem ...... -existing psychiatric factors.
@en
Problematic versus non-problem ...... -existing psychiatric factors.
@nl
type
label
Problematic versus non-problem ...... -existing psychiatric factors.
@en
Problematic versus non-problem ...... -existing psychiatric factors.
@nl
prefLabel
Problematic versus non-problem ...... -existing psychiatric factors.
@en
Problematic versus non-problem ...... -existing psychiatric factors.
@nl
P2093
P2860
P356
P1476
Problematic versus non-problem ...... -existing psychiatric factors.
@en
P2093
P2860
P304
P356
10.1177/0269881106063274
P407
P577
2006-05-01T00:00:00Z